 | AbbVie Forms Flat Base Ahead Of Q3 Earnings Report
marketbeat.com - October 13 at 6:10 AM |
 | AbbVie: The Humira Situation Remains Scary
seekingalpha.com - October 15 at 3:16 PM |
| AbbVie: The Humira Situation Remains Scary - Seeking Alpha
seekingalpha.com - October 15 at 2:57 PM |
 | AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
finance.yahoo.com - October 15 at 9:56 AM |
| AbbVie Inc.: Dissect Its Growth Sustainability And Capital Allocation Like Buffett - Seeking Alpha
seekingalpha.com - October 12 at 1:01 PM |
| Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness
finance.yahoo.com - October 11 at 9:11 AM |
| Eli Lilly, AbbVie favorites at JP Morgan as big pharma set for Q3 earnings (NYSE:MRK) - Seeking Alpha
seekingalpha.com - October 9 at 11:33 PM |
 | Is It Worth Considering AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend? - Nasdaq
nasdaq.com - October 9 at 1:32 PM |
| AbbVie Vs. Moderna Stock: Which Is The Better Buy?
seekingalpha.com - October 8 at 7:47 AM |
 | Why AbbVie Stock Sank in September - Motley Fool
fool.com - October 7 at 1:37 PM |
|
| Why AbbVie Stock Sank in September
finance.yahoo.com - October 7 at 1:37 PM |
| Health Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis
finance.yahoo.com - October 7 at 1:37 PM |
| AbbVie's RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis - Yahoo Finance
finance.yahoo.com - October 7 at 8:36 AM |
| AbbVie's RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis
finance.yahoo.com - October 7 at 8:36 AM |
| AbbVie's Upadacitinib (RINVOQ®) Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis
finance.yahoo.com - October 7 at 8:36 AM |
| AbbVie Stock Is Making A Comeback On Inflammatory Drugs — Is It A Buy Now?
finance.yahoo.com - October 6 at 5:37 PM |
| AbbVie to Host Third-Quarter 2021 Earnings Conference Call
finance.yahoo.com - October 5 at 8:53 AM |
| AbbVie Appears Ready To Reverse And Outperform
seekingalpha.com - October 5 at 6:30 AM |
| AbbVie (ABBV) Stock Moves -0.33%: What You Should Know - Nasdaq
nasdaq.com - October 4 at 10:51 PM |
| AbbVie (ABBV) Stock Moves -0.33%: What You Should Know
finance.yahoo.com - October 4 at 10:51 PM |
| Is AbbVie A Good Dividend Stock? Perceived Risks Offer Tremendous Value - Seeking Alpha
seekingalpha.com - October 4 at 5:50 PM |
| Botox war: East Bay challenger sued by maker of blockbuster cosmetic toxin
finance.yahoo.com - October 4 at 5:50 PM |
 | AbbVie Presents New Upadacitinib Data In Atopic Dermatitis - Benzinga
benzinga.com - September 30 at 9:25 PM |
| Abbvie data shows Skyrizi efficacy in psoriatric arthritis maintained for a year - Seeking Alpha
seekingalpha.com - September 30 at 4:25 PM |
| AbbVie Presents New Analyses Evaluating RINVOQ® (upadacitinib) in Atopic Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress - Yahoo Finance
finance.yahoo.com - September 30 at 11:24 AM |
| AbbVie Presents Late-Breaking Data on Risankizumab (SKYRIZI®) in Psoriatic Arthritis at the 30th European Academy of Dermatology and Venereology (EADV) Congress - Yahoo Finance
finance.yahoo.com - September 30 at 11:24 AM |
| AbbVie Presents New Analyses Evaluating RINVOQ® (upadacitinib) in Atopic Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress
finance.yahoo.com - September 30 at 11:24 AM |
| AbbVie Presents Late-Breaking Data on Risankizumab (SKYRIZI®) in Psoriatic Arthritis at the 30th European Academy of Dermatology and Venereology (EADV) Congress
finance.yahoo.com - September 30 at 11:24 AM |
 | U.S. FDA approves AbbVie's migraine prevention drug - Reuters
reuters.com - September 29 at 8:23 PM |
| The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug - Yahoo Finance
finance.yahoo.com - September 29 at 3:22 PM |
| AbbVie's (ABBV) Migraine Prevention Drug Qulipta Gets FDA Nod
finance.yahoo.com - September 29 at 3:22 PM |
| Here's Why AbbVie Is a Great Healthcare Stock for Long-Term Investors - Motley Fool
fool.com - September 29 at 9:53 AM |
|
| Here's Why AbbVie Is a Great Healthcare Stock for Long-Term Investors
fool.com - September 29 at 8:59 AM |
| Could AbbVie's New Collaboration Be a Blockbuster? - The Motley Fool
fool.com - September 29 at 2:37 AM |
| UPDATE 1-U.S. FDA approves AbbVie's migraine prevention drug
finance.yahoo.com - September 29 at 2:37 AM |
| Regenxbio: Unlocking Value Through The Mega AbbVie Partnership
seekingalpha.com - September 27 at 7:47 PM |
| AbbVie Is A Cheap Large Cap With New Drugs To Come - Seeking Alpha
seekingalpha.com - September 27 at 5:39 PM |
| AbbVie: When The Going Gets Tough - Seeking Alpha
seekingalpha.com - September 27 at 12:39 PM |
| Americans are Frustrated by Unexpected Blurry Near Vision Issues, a New Survey Reveals
finance.yahoo.com - September 27 at 12:39 PM |
| Could AbbVie's New Collaboration Be a Blockbuster? - Nasdaq
nasdaq.com - September 27 at 7:35 AM |
| AbbVie unveils valuation discount after selloff amid mixed views on its prospects - Seeking Alpha
seekingalpha.com - September 25 at 11:32 PM |
| AbbVie unveils valuation discount after selloff amid mixed views on its prospects
seekingalpha.com - September 25 at 9:53 PM |
| Welcoming New Positions In AbbVie And VICI Properties - Seeking Alpha
seekingalpha.com - September 24 at 9:43 AM |
| Welcoming New Positions In AbbVie And VICI Properties
seekingalpha.com - September 24 at 4:46 AM |
| 4.9% Yielding AbbVie Is The Best Buffett Aristocrat Bargain You Can Buy
seekingalpha.com - September 24 at 2:12 AM |
| 4.9% Yielding AbbVie Is The Best Buffett Aristocrat Bargain You Can Buy - Seeking Alpha
seekingalpha.com - September 24 at 12:17 AM |
| November 5th Options Now Available For AbbVie - Nasdaq
nasdaq.com - September 23 at 1:58 PM |
| AbbVie Presents New Data Analyses for Growing Dermatology Portfolio at the 30th European Academy of Dermatology and Venereology (EADV) Congress - Yahoo Finance
finance.yahoo.com - September 23 at 1:58 PM |
| 3 Relatively Safe Pharma Stocks You Can Buy Right Now - Motley Fool
fool.com - September 23 at 8:57 AM |
| 3 Relatively Safe Pharma Stocks You Can Buy Right Now
finance.yahoo.com - September 23 at 8:57 AM |
| AbbVie Presents New Data Analyses for Growing Dermatology Portfolio at the 30th European Academy of Dermatology and Venereology (EADV) Congress
finance.yahoo.com - September 23 at 8:57 AM |
